| US 7,550,481 B2 | ||
| Phenylamide and pyridylamide beta-secretase inhibitors for the treatment of Alzheimer's disease | ||
| James C. Barrow, Harleysville, Pa. (US); Craig A. Coburn, Royersford, Pa. (US); Philippe G. Nantermet, Lansdale, Pa. (US); Harold G. Selnick, Ambler, Pa. (US); Shawn J. Stachel, Perkasie, Pa. (US); Matthew G. Stanton, Lansdale, Pa. (US); Shaun R. Stauffer, Schwenksville, Pa. (US); Linghang Zhuang, Chalfont, Pa. (US); and Jennifer R. Davis, Richboro, Pa. (US) | ||
| Assigned to Merck & Co., Inc., Rahway, N.J. (US) | ||
| Appl. No. 10/582,856 PCT Filed Dec. 15, 2004, PCT No. PCT/US2004/042173 § 371(c)(1), (2), (4) Date Jun. 14, 2006, PCT Pub. No. WO2005/065195, PCT Pub. Date Jul. 21, 2005. |
||
| Claims priority of provisional application 60/531423, filed on Dec. 19, 2003. | ||
| Prior Publication US 2007/0142634 A1, Jun. 21, 2007 | ||
| Int. Cl. C07D 401/02 (2006.01); A61K 31/44 (2006.01) | ||
| U.S. Cl. 514—307 [514/310; 514/313; 514/314; 514/342; 514/343; 514/352; 514/619; 546/143; 546/144; 546/159; 546/276.4; 546/280.4; 546/304; 546/307; 546/312; 564/161] | 21 Claims |
1. A compound of formula (I):
![]() Y1 is CH or N;
Q1 is —OH;
Q2 and Q3 independently selected from the group consisting of
(1) hydrogen, and
(2) halogen;
Ra is hydrogen;
Rb is selected from the group consisting of
(1) hydrogen, and
(2) —C1-10 alkyl,
(3) —(CH2)n—NRcRd wherein Rc and Rd are selected from the group consisting of hydrogen and C1-10 alkyl, and n is 2, 3 or 4, and
(4) —(CH2)n′—O—Re, wherein Re is selected from the group consisting of
(a) C1-10 alkyl,
(b) —C0-3 alkyl-aryl, wherein said aryl is selected from the group consisting of phenyl and naphthyl,
wherein said alkyl and aryl are unsubstituted or substituted with one or more
(i) halo,
(ii) —OH,
(iii) —CN,
(iv) —O—C1-10 alkyl,
and n′ is 1, 2, 3 or 4;
m is 1 or 2;
R1 is
(1) aryl selected from the group consisting of phenyl and napthyl, or
(2) heteroaryl selected from the group consisting of pyrazinyl, pyrazolyl, pyridazinyl, pyridyl, pyrimidinyl, pyrrolyl, tetrazolyl,
furanyl, imidazolyl, triazinyl, pyranyl, thiazolyl, thienyl, thiophenyl, triazolyl, oxazolyl, isoxazolyl, thiazolyl, oxadiazolyl,
indolyl, quinolinyl, isoquinolinyl, benzimidazolyl and benzoxazolyl,
(3) —C1-10 alkyl, and
(4) —C3-8 cycloalkyl,
wherein said aryl, heteroaryl, alkyl and cycloalkyl is unsubstituted or substituted with one or more
(a) halo,
(b) —OH,
(c) —CN,
(d) —O—C1-10 alkyl,
(e) —C1-10 alkyl,
(f) —C3-8 cycloalkyl,
(g) aryl selected from the group consisting of phenyl and napthyl, or
(h) heteroaryl selected from the group consisting of pyrazinyl, pyrazolyl, pyridazinyl, pyridyl, pyrimnidinyl, pyrrolyl, tetrazolyl,
furanyl, imidazolyl, triazinyl, pyranyl, thiazolyl, thienyl, thiophenyl, triazolyl, oxazolyl, isoxazolyl, thiazolyl, oxadiazolyl,
indolyl, quinolinyl, isoquinolinyl, benzimidazolyl and benzoxazolyl;
R2 is selected from the group consisting of:
(1) (R4—SO2)N(R7)—, wherein R4 is
(a) —C1-10 alkyl,
(b) —C3-8 cycloalkyl,
wherein said alkyl and cycloalkyl is unsubstituted or substituted with one or more
(i) halo,
(ii) —OH,
(iii) —CN,
(iv) —O—C1-10 alkyl,
(v) —C1-10 alkyl,
(vi) —C3-8 cycloalkyl,
(vii) aryl selected from the group consisting of phenyl and napthyl, or
(viii) heteroaryl selected from the group consisting of pyrazinyl, pyrazolyl, pyridazinyl, pyridyl, pyrimidinyl, pyrrolyl,
tetrazolyl, furanyl, imidazolyl, triazinyl, pyranyl, thiazolyl, thienyl, thiophenyl, triazolyl, oxazolyl, isoxazolyl, thiazolyl,
oxadiazolyl, indolyl, quinolinyl, isoquinolinyl, benzimidazolyl and benzoxazolyl;
and said aryl and heteroaryl is unsubstituted or substituted with one or more
(A) halo,
(B) —OH,
(C) —CN,
(D) —O—C1-10 alkyl,
(E) —C3-8 cycloalkyl, or
(F) —C1-10 alkyl,
(c) heteroaryl selected from the group consisting of pyrazinyl, pyrazolyl, pyridazinyl, pyridyl, pyrimidinyl, pyrrolyl, tetrazolyl,
furanyl, imidazolyl, triazinyl, pyranyl, thiazolyl, thienyl, thiophenyl, triazolyl, oxazolyl, isoxazolyl, thiazolyl, oxadiazolyl,
indolyl, quinolinyl, isoquinolinyl, benzimidazolyl and benzoxazolyl,
wherein said heteroaryl is unsubstituted or substituted with one or more
(i) halo,
(ii) —OH,
(iii) —CN,
(iv) —O—C1-10 alkyl,
(v) —C3-8 cycloalkyl, or
(vi) —C1-10 alkyl,
(d) —CH2)x—NRfRg wherein Rf and Rg are selected from the group consisting of hydrogen and C1-10 alkyl, and x is 0, 1, 2, 3 or 4, or Rf and Rg, together with the nitrogen atom to which they are attached form the group
![]() wherein y is 1 or 2, Y5 is —CHR21, —O— or NR21, wherein R21 is selected from the group consisting of;
(i) hydrogen, and
(ii) C1-10 alkyl,
wherein said alkyl is unsubstituted or substituted with one or more
(A) halo,
(B) —OH,
(C) —CN,
(D) —O—C1-10 alkyl, or
(E) —C3-8 cycloalkyl;
R7 is selected from the group consisting of
(a) hydrogen, and
(b) —C1-10 alkyl,
(c) aryl selected from the group consisting of phenyl and napthyl, or
(d) heteroaryl selected from the group consisting of pyrazinyl, pyrazolyl, pyridazinyl, pyridyl, pyrimidinyl, pyrrolyl, tetrazolyl,
furanyl, imidazolyl, triazinyl, pyranyl, thiazolyl, thienyl, thiophenyl, triazolyl, oxazolyl, isoxazolyl, thiazolyl, oxadiazolyl,
indolyl, quinolinyl, isoquinolinyl, benzimidazolyl and benzoxazolyl
wherein said alkyl, aryl and heteroaryl is unsubstituted or substituted with one or more
(i) halo,
(ii) —OH,
(iii) —CN,
(iv) —O—C1-10 alkyl,
(v) —C3-8 cycloalkyl,
(vi) aryl selected from the group consisting of phenyl and napthyl, or
(vii) heteroaryl selected from the group consisting of pyrazinyl, pyrazolyl, pyridazinyl, pyridyl, pyrimidinyl, pyrrolyl,
tetrazolyl, furanyl, imidazolyl, triazinyl, pyranyl, thiazolyl, thienyl, thiophenyl, triazolyl, oxazolyl, isoxazolyl, thiazolyl,
oxadiazolyl, indolyl, quinolinyl, isoquinolinyl, benzimidazolyl and benzoxazolyl,
wherein said cycloalkyl, aryl or heteroaryl is unsubstituted or substituted with one or more
(A) halo,
(B) —OH,
(C) —CN,
(D) —O—C1-10 alkyl,
(E) —C3-8 cycloalkyl, or
(F) aryl selected from the group consisting of phenyl and napthyl;
(e) —(CH2)y′—NRhRi wherein Rh and Ri are selected from the group consisting of hydrogen and C1-10 alkyl, and y′ is 1, 2, 3 or 4, or or Rh and Ri, together with the nitrogen atom to which they are attached from the group
![]() wherein y′ is 1 or 2, Y6 is —CHR22, —O— or NR22, wherein R22 is selected from the group consisting of;
(i) hydrogen, and
(ii) C1-10 alkyl,
wherein said alkyl is unsubstituted or substituted with one or more
(A) halo,
(B) —OH,
(C) —CN,
(D) —O—C1-10 alkyl, or
(E) —C3-8 cycloalkyl,
or R4 and R7 are linked together to form the group
![]() wherein z is 1, 2 or 3; or
![]() wherein z is 1, 2 or 3
![]() wherein R8 is selected from the group consisting of
(a) —CN,
(b) hydrogen, and
(c) tetrazolyl;
![]() wherein o is 1, 2, 3 or 4; and
![]() wherein Y2 is —NH═CH— or —CH═NH—;
R3 is selected from the group consisting of
![]() wherein Y3 is CR6c or N;
R5 is C1-10 alkyl or C1-2 perfluoroalkyl;
R6a, R6b, and R6c are independently selected from the group consisting of:
(1) hydrogen,
(2) halo,
(3) —C1-10 alkyl,
(4) —OH,
(5) —CN,
(6) —C3-8 cycloalkyl, and
(7) —O—C1-10 alkyl;
R9 and R10 are independently selected from the group consisting of
(1) hydrogen,
(2) —C1-10 alkyl, and
(3) —C3-8 cycloalkyl,
wherein said alkyl and cycloalkyl are unsubstituted or substituted with one or more
(a) halo,
(b) —OH,
(c) —CN,
(d) —O—C1-10 alkyl,
(e) —C3-8 cycloalkyl, and
(f) —NRjRk wherein Rj and Rk are C1-10 alkyl;
or R9 and R10 are joined together with the nitrogen atom to which they are attached to form
![]() wherein w is 1, 2 or 3, and
R23 is selected from the group consisting of
(a) hydrogen,
(b) —C1-10 alkyl,
(c) —C3-8 cycloalkyl,
(d) —C2-10 alkenyl,
(e) —C2-10 alkynyl,
(f) —(CH2)p-phenyl,
(g) —(CH2)p-heteroaryl, wherein said heteroaryl is selected from the group consisting of pyrazinyl, pyrazolyl, pyridazinyl, pyridyl,
pyrimidinyl, pyrrolyl, tetrazolyl, furanyl, imidazolyl, triazinyl, pyranyl, thiazolyl, thienyl, thiophenyl, triazolyl, oxazolyl,
isoxazolyl, thiazolyl, oxadiazolyl, indolyl, quinolinyl, isoquinolinyl, benzimidazolyl and benzoxazolyl,
wherein p is 0 or 1, and
wherein said alkyl, alkenyl, alkynyl, cycloalkyl, phenyl and heteroaryl is unsubstituted or substituted with one or more
(i) halo,
(ii) —C1-10 alkyl,
(iii) —OH,
(iv) —CN,
(v) —C3-8 cycloalkyl, or
(vi) —O—C1-10 alkyl;
R11 is selected from the group consisting of
(1) —CH—
(2) —CH2—,
(3) —O—, and
(4) —NR17—,
provided that when R11 is —CH— the dotted line forms a bond and when R11 is —CH2—, —O— or —NR17— the dotted line is absent;
R17 is hydrogen or C1-10 alkyl, wherein said C1-10 alkyl is unsubstituted or substituted with one or more
(a) halo,
(b) —OH,
(c) —CN,
(d) —C3-8 cycloalkyl,
(e) —O—C1-10 alkyl,
(f) —(CH2)q-phenyl, wherein q is 1 or 2, and
(g) —NR18R19, and
wherein R18 and R19 are independently selected from the group consisting of
(i) hydrogen, or
(ii) C1-10 alkyl;
or R18 and R19, together with the nitrogen atom to which they are attached, form the group
![]() wherein q′ is 1 or 2, Y7 is —CHR24, —O— or NR24, wherein R24 is selected from the group consisting of;
(a) hydrogen, and
(b) C1-10 alkyl,
wherein said alkyl is unsubstituted or substituted with one or more
(i) halo,
(ii) —OH,
(iii) —CN,
(iv) —O—C1-10 alkyl, or
(v) —C3-8 cycloalkyl;
R26 is selected from the group consisting of
(1) hydrogen,
(2) —C1-3 alkyl;
R12 is selected from the group consisting of
(1) hydrogen,
(2) —C1-10 alkyl, wherein said alkyl is unsubstituted or substituted with one or more
(a) halo,
(b) —OH,
(c) —CN,
(d) —C3-8 cycloalkyl,
(e) —O—C1-10 alkyl, or
(f) —NH2,
(3) halo,
(4) —C3-8 cycloalkyl,
(5) aryl selected from the group consisting of phenyl and napthyl, and
(6) heteroaryl selected from the group consisting of pyrazinyl, pyrazolyl, pyridazinyl, pyridyl, pyrimidinyl, pyrrolyl, tetrazolyl,
furanyl, imidazolyl, triazinyl, pyranyl, thiazolyl, thienyl, thiophenyl, triazolyl, oxazolyl, isoxazolyl, thiazolyl, oxadiazolyl,
indolyl, quinolinyl, isoquinolinyl, benzimidazolyl and benzoxazolyl,
wherein said aryl and heteroaryl is unsubstituted or substituted with one or more
(a) halo,
(b) —OH,
(c) —CN,
(d) —O—C1-10 alkyl,
(e) —C3-8 cycloalkyl, or
(f) —C1-10 alkyl;
R13 is selected from the group consisting of
(1) hydrogen,
(2) C1-10 alkyl, and
(3) —C3-8 cycloalkyl;
wherein said alkyl and cycloalkyl is unsubstituted or substituted with one or more
(a) halo,
(b) —OH,
(c) —CN,
(d) —C3-8 cycloalkyl,
(e) —O—C1-10 alkyl, and
(f) —C1-10 alkyl;
R14 is selected from the group consisting of
(1) —C1-10 alkyl, and
(2) —C3-8 cycloalkyl;
wherein said alkyl and cycloalkyl is unsubstituted or substituted with one or more
(a) halo,
(b) —OH,
(c) —CN
(d) —C3-8 cycloalkyl,
(e) —O—C1-10 alkyl, or
(f) —C1-10 alkyl;
(3) —(CH2)v—NR15R16, wherein v is 2, 3 or 4, and
wherein R15 and R16 are independently selected from the group consisting of
a) hydrogen, or
b) C1-10 alkyl, wherein said C1-10 alkyl is unsubstituted or substituted with one or more
(i) halo,
(ii) —OH,
(iii) —CN,
(iv) —C3-8 cycloalkyl, or
(v) —O—C1-10 alkyl;
or R15 and R16, together with the nitrogen atom to which they are attached, form the group
![]() wherein s is 1 or 2, Y4 is —CHR24—, —O— or —NR24—, wherein R24 is selected from the group consisting of
(i) hydrogen, and
(ii) C1-10 alkyl,
wherein said alkyl is unsubstituted or substituted with one or more
(A) halo,
(B) —OH,
(C) —CN,
(D) —O—C1-10 alkyl, or
(E) —C3-8 cycloalkyl,
(4) —(CH2)r-phenyl, wherein r is 1, 2, 3, or 4, and
wherein said phenyl is unsubstituted or substituted with one or more
(a) halo,
(b) —OH,
(c) —CN,
(d) —O—C1-10 alkyl,
(e) —C3-8 cycloalkyl, or
(f) —C1-10 alkyl;
or R13 and R14, together with the nitrogen atom to which they are attached, form the group
![]() wherein u is 1 or 2, Y8 is —CHR25—, —O— or —NR25—, wherein R25 is selected from the group consisting of
(a) hydrogen,
(b) C1-10 alkyl,
(c) —(CH2)t-phenyl,
(d) —(CH2)t-heteroaryl, wherein said heteroaryl is selected from the group consisting of pyrazinyl, pyrazolyl, pyridazinyl, pyridyl,
pyrimidinyl, pyrrolyl, tetrazolyl, furanyl, imidazolyl, triazinyl, pyranyl, thiazolyl, thienyl, thiophenyl, triazolyl, oxazolyl,
isoxazolyl, thiazolyl, oxadiazolyl, indolyl, quinolinyl, isoquinolinyl, benzimidazolyl and benzoxazolyl,
wherein t is 0 or 1, and
wherein said alkyl, phenyl and heteroaryl is unsubstituted or substituted with one or more
(i) halo,
(ii) —C1-10 alkyl,
(iii) —OH,
(iv) —CN,
(v) —C3-8 cycloalkyl, or
(vi) —O—C1-10 alkyl;
or a pharmaceutically acceptable salt thereof.
|